What is a stock summary page? Click here for an overview.
Royalty Pharma PLC (NAS:RPRX) Stock News, Headlines & Updates
Royalty Pharma PLC Stock News from GuruFocus
- 1
Apr 24, 2025
U.S. FDA Approves Second Drug Product Manufacturing Facility for ADSTILADRIN® (nadofaragene firadenovec-vncg) | RPRX Stock News
GuruFocus News • 7:48am
Apr 21, 2025
Royalty Pharma Declares Second Quarter 2025 Dividend
Marketwired • 4:00pm
Royalty Pharma Declares Second Quarter 2025 Dividend | RPRX Stock News
GuruFocus News • 3:33pm
Royalty Pharma (RPRX) Price Target Raised to $42 by BofA Amid Q1 Preview | RPRX Stock News
GuruFocus News • 9:02am
Apr 17, 2025
Royalty Pharma PLC (RPRX) Announces Upcoming First Quarter 2025 Financial Results Release | RPRX stock news
GuruFocus News • 4:07pm
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025
Marketwired • 4:00pm
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025 | RPRX Stock News
GuruFocus News • 3:33pm
Apr 08, 2025
Royalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of Directors | RPRX Stock News
GuruFocus News • 4:22pm
Royalty Pharma PLC Appoints Vlad Coric to Board of Directors
GuruFocus News • 4:04pm
Royalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of Directors
Marketwired • 4:00pm
Mar 27, 2025
Royalty Pharma PLC Announces Investor Day to Highlight Shareholder Value Creation
GuruFocus News • 8:13am
Royalty Pharma Announces Upcoming Investor Day
Marketwired • 8:00am
Feb 27, 2025
Royalty Pharma PLC (RPRX) to Participate in TD Cowen's 45th Annual Health Care Conference
GuruFocus News • 4:04pm
Royalty Pharma to Present at TD Cowen's 45th Annual Health Care Conference
Marketwired • 4:00pm
Feb 13, 2025
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
GuruFocus News • 11:26pm
Feb 12, 2025
FMR LLC Reduces Holdings in Royalty Pharma PLC
GuruFocus News • 12:46pm
Royalty Pharma PLC Invests $250 Million in Biogen's Lupus Treatment Development
GuruFocus News • 6:07am
Royalty Pharma Announces R&D Funding Collaboration With Biogen
Marketwired • 6:00am
Royalty Pharma PLC (RPRX) Q4 2024 Earnings Call Highlights: Strong Financial Performance and Strategic Initiatives
GuruFocus News • 1:07am
Q4 2024 Royalty Pharma PLC Earnings Call Transcript
GuruFocus News • 11:07pm
Feb 11, 2025
Royalty Pharma PLC (RPRX) Reports Strong 2024 Financial Results and Announces 2025 Guidance
GuruFocus News • 7:07am
Royalty Pharma Reports Q4 and Full Year 2024 Results
Marketwired • 7:00am
Royalty Pharma PLC Q4 2024 Earnings: Revenue Surpasses Estimates at $742 Million
GuruFocus News • 6:57am
Feb 04, 2025
BlackRock, Inc.'s Strategic Acquisition of Royalty Pharma PLC Shares
GuruFocus News • 4:06pm
Jan 29, 2025
Royalty Pharma PLC (RPRX) Monetizes MorphoSys Bonds for $530 Million
GuruFocus News • 9:03am
Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds
Marketwired • 8:00am
Jan 28, 2025
Royalty Pharma PLC (RPRX) Announces Upcoming Financial Results Release
GuruFocus News • 4:03pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news